Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: A propensity score weighted landmark analysis
Alimentary Pharmacology and Therapeutics Sep 25, 2017
Wong JCT, et al. - The effects of statin use on the risk of liver decompensation and death among patients with chronic viral hepatitis were determined. This propensity score weighted landmark analysis concluded that compared to non-users, patients with chronic viral hepatitis who used statins had a reduced risk of liver decompensation and death.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
